Login
| TI Ref No : | 525926374 |
|---|---|
| Description : | Contract Awarded For Delivery Of A Medicinal Product Containing The Active Substance Mirvetuximab Soravtansine Reimbursed Under The Drug Program B.50. Treatment Of Patients With Ovarian Cancer, Fallopian Tube Cancer, Or Peritoneal Cancer. delivery Of A Me |
| Date : | 2025-12-06 |
| Deadline : | 2026-01-27 |
| Document Type : | Contracts |
